Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Targeting HOX transcription factors in prostate cancer

  • Richard Morgan1Email author,
  • Angie Boxall1,
  • Kevin J Harrington2,
  • Guy R Simpson1,
  • Agnieszka Michael1 and
  • Hardev S Pandha1
BMC Urology201414:17

DOI: 10.1186/1471-2490-14-17

Received: 16 October 2013

Accepted: 30 January 2014

Published: 5 February 2014

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
16 Oct 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
21 Oct 2013 Author responded Author comments - Richard Morgan
Resubmission - Version 3
21 Oct 2013 Submitted Manuscript version 3
16 Nov 2013 Reviewed Reviewer Report - Steven Nordeen
27 Nov 2013 Reviewed Reviewer Report - Zongbing You
14 Jan 2014 Author responded Author comments - Richard Morgan
Resubmission - Version 4
14 Jan 2014 Submitted Manuscript version 4
27 Jan 2014 Author responded Author comments - Richard Morgan
Resubmission - Version 5
27 Jan 2014 Submitted Manuscript version 5
29 Jan 2014 Author responded Author comments - Richard Morgan
Resubmission - Version 6
29 Jan 2014 Submitted Manuscript version 6
Publishing
30 Jan 2014 Editorially accepted
5 Feb 2014 Article published 10.1186/1471-2490-14-17

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Faculty of Health and Medical Sciences, University of Surrey
(2)
Targeted Therapy Team, Chester Beatty Laboratories, The Institute of Cancer Research

Advertisement